From: Attention to COVID 19 pandemic resulted in increased measles cases and deaths in Zambia
Vaccine | Age of administration | Purpose/target disease | Doses required |
---|---|---|---|
Bacillus Calmette–Guérin (BCG) | At birth | Tuberculosis | 1 |
Oral Polio Vaccine (OPV) | At birth, 6Â weeks, 10 weeks, 14 weeks | Polio | 4 |
Pentavalent Vaccine (DTP-HepB-Hib) | 6 weeks, 10 weeks, 14 weeks | Diphtheria, Pertussis, Tetanus, Hepatitis B, Haemophilus influenzae type b | 3 |
Measles-Containing Vaccine (MCV1) | 9 months | Measles | 1 |
Measles-Containing Vaccine (MCV2) | 18 months | Measles | 1 |
Rotavirus Vaccine | 6 weeks, 10 weeks | Severe diarrhea caused by rotavirus | 2 |
Pneumococcal Conjugate Vaccine (PCV) | 6 weeks, 10 weeks, 14 weeks | Pneumonia, Meningitis caused by pneumococcus | 3 |
Human Papillomavirus (HPV) Vaccine | 9 years (for girls) | Cervical cancer | 2 |